scholarly article | Q13442814 |
P356 | DOI | 10.1016/0882-4010(90)90030-T |
P698 | PubMed publication ID | 2266855 |
P2093 | author name string | Hultenby K | |
Stocker BA | |||
Lindberg AA | |||
Sweiha H | |||
Pál T | |||
Karnell A | |||
P433 | issue | 6 | |
P921 | main subject | Shigella flexneri | Q1644417 |
P304 | page(s) | 433-440 | |
P577 | publication date | 1990-06-01 | |
P1433 | published in | Microbial Pathogenesis | Q15766470 |
P1476 | title | Construction of an auxotrophic Shigella flexneri strain for use as a live vaccine. | |
P478 | volume | 8 |
Q33801151 | A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection |
Q39518014 | Aromatic compound-dependent Brucella suis is attenuated in both cultured cells and mouse models. |
Q42605206 | Characterization of a 3-dehydroquinase gene from Actinobacillus pleuropneumoniae with homology to the eukaryotic genes qa-2 and QUTE. |
Q35548702 | Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1. |
Q39573053 | Construction of a stable attenuated Shigella sonnei DeltavirG vaccine strain, WRSS1, and protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model |
Q33617990 | Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo |
Q37458618 | Effect of wild-type Shigella species and attenuated Shigella vaccine candidates on small intestinal barrier function, antigen trafficking, and cytokine release |
Q35510455 | Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine |
Q35594674 | Expression of Shigella dysenteriae serotype 1 O-antigenic polysaccharide by Shigella flexneri aroD vaccine candidates and different S. flexneri serotypes |
Q34336847 | Identification of critical residues of the serotype modifying O-acetyltransferase of Shigella flexneri |
Q40706785 | Immune responses in Vietnamese children after a single dose of the auxotrophic, live Shigella flexneri Y vaccine strain SFL124. |
Q46553139 | Immunogenicity of the Shigella flexneri serotype Y (SFL 124) vaccine strain expressing cloned glucosyl transferase gene of converting bacteriophage SfX. |
Q39569905 | Intracellular multiplication and virulence of Shigella flexneri auxotrophic mutants. |
Q53850288 | Live oral auxotrophic Shigella flexneri SFL124 vaccine with a deleted aroD gene: Characterization and monkey protection studies |
Q35528270 | Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG. |
Q43828620 | Serological cross-reaction between O-antigens of Shigella dysenteriae type 4 and an environmental Escherichia albertii isolate. |
Q34003433 | Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans |
Q42664186 | Shigella flexneri type-specific antigen V: cloning, sequencing and characterization of the glucosyl transferase gene of temperate bacteriophage SfV. |
Q36989057 | Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains |
Q34000330 | Strategy for cross-protection among Shigella flexneri serotypes |
Search more.